Literature DB >> 3815031

Prognostic significance of the DNA content of human breast cancer.

C S Dowle, A Owainati, A Robins, K Burns, I O Ellis, C W Elston, R W Blamey.   

Abstract

The DNA content of paraffin embedded primary tumour tissue has been measured by flow cytometry in 354 patients with operable breast cancer. Tumour ploidy significantly correlated with tumour size, histological grade, and with menopausal status. No significant correlation with oestrogen receptor status or lymph node involvement was found. Patients with diploid cancers had a significantly improved short term survival and disease-free interval (DFI) compared with patients having aneuploid tumours. However, no difference in survival or DFI was shown after longer term follow-up (median 84 months). Multivariate analysis showed no independently significant prognostic value for tumour ploidy. No patient in this study received adjuvant therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3815031     DOI: 10.1002/bjs.1800740221

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  21 in total

Review 1.  Preoperative assessment of prognostic factors in breast cancer.

Authors:  H Denley; S E Pinder; C W Elston; A H Lee; I O Ellis
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 3.  Aneuploidy as a prognostic factor in breast cancer.

Authors:  A von Rosen
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

4.  Node negative breast cancer.

Authors:  R W Blamey; C W Elston; I O Ellis; D A Morgan; J L Haybittle
Journal:  BMJ       Date:  1990-04-28

5.  Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: correlation and relative prognostic influence.

Authors:  T Hatschek; O Gröntoft; G Fagerberg; O Stål; S Sullivan; J Carstensen; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

6.  Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.

Authors:  A E Pinto; S André; M Nogueira; E Mendonça; J Soares
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

7.  Cellular effects of tamoxifen in primary breast cancer.

Authors:  J F Robertson; I O Ellis; R I Nicholson; A Robins; J Bell; R W Blamey
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

8.  Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.

Authors:  A von Rosen; L E Rutqvist; J Carstensen; A Fallenius; L Skoog; G Auer
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

9.  Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.

Authors:  S A Brooks; A J Leathem; R S Camplejohn; W Gregory
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.

Authors:  L Pedersen; J K Larsen; I J Christensen; A Lykkesfeldt; S Holck; T Schiødt
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.